Results 21 to 30 of about 65,570 (200)

Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study [PDF]

open access: yesIntestinal Research, 2019
Background/Aims Polypharmacy is a common clinical problem with chronic diseases that can be associated with adverse patient outcomes. The present study aimed to determine the prevalence and patient-specific characteristics associated with polypharmacy in
Jingzhou Wang   +3 more
doaj   +1 more source

Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy - a prospective randomised controlled trial [PDF]

open access: yes, 2016
In 2010 the 'Polymedication Check' (PMC), a pharmacist-led medication review, was newly introduced to be delivered independently from the prescriber and reimbursed by the Swiss health insurances.
Vriends, Noortje   +11 more
core   +1 more source

Prevalence of polypharmacy in the older adult population within primary care in Portugal: a nationwide cross-sectional study [PDF]

open access: yes, 2020
Introduction Polypharmacy is commonly defined as the simultaneous use of five or more medications; however, there is a lack of consensus regarding the most appropriate definition. It is a significant predictor of morbidity and mortality. The aim of this
Santiago, Luiz Miguel de Mendonça Soares   +2 more
core   +1 more source

Risk of Self-Medication Practices, Polypharmacy and Drug Interactions Among Elderly Patients

open access: yes, 2021
Drug-drug interactions are becoming more frequent in health care as a risk factor responsible for many emergency cases and clinic visits. Polypharmacy is affecting more and more people, and it is higher among the elderlies who are on a high number of ...
Afsan, Yazan
core   +1 more source

Polypharmacy among community-dwelling elderly in Singapore: Prevalence, risk factors and association with medication non-adherence

open access: yesProceedings of Singapore Healthcare, 2019
Background: Polypharmacy, given its link with drug interactions, potentially inappropriate medications and medication non-adherence, may pose a significant health risk, especially among the elderly.
Yi Wen Tan   +3 more
doaj   +1 more source

Prevalence and predictors of polypharmacy among Korean elderly.

open access: yesPLoS ONE, 2014
ObjectivePolypharmacy is widespread in the elderly because of their multiple chronic health problems. The objective of this study was to investigate the prevalence and predictors associated with polypharmacy in a nationally representative sample of ...
Hong-Ah Kim   +3 more
doaj   +1 more source

Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens

open access: yesFrontiers in Pharmacology, 2021
Introduction: Polypharmacy is a risk factor for adverse health outcomes, higher use of medical services and additional costs. The problem has gained attention as a consequence of aging and related multimorbidity.
Przemysław Kardas   +5 more
doaj   +1 more source

Adherence to polypharmacy - use of multidrug punch cards in primary care [PDF]

open access: yes, 2015
Adherence is defined as ‘the extent to which a person’s behavior – taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider’.
Böni, Fabienne
core   +1 more source

Polypharmacy and the coproduction of the experience between physicians and patients

open access: yesTeoria e Prática em Administração, 2021
Purpose: To identify how physicians can help polypharmacy patients deal with their disease condition by focusing on the non-clinical factors of care processes.
Md Mafuzul Huq   +2 more
doaj   +1 more source

Evaluation of Polypharmacy and Drug Interactions in the Treatment of Patients with Sepsis [PDF]

open access: yes, 2021
Objective:Comprehensive and supportive therapies of sepsis and septic shock (SSS) cause polypharmacy and increase the risk of drug interactions. This study aimed to evaluate the rate of polypharmacy, potential drug interactions, and clinical pharmacists’
Nursel Sürmelioğlu, Kutay Demirkan
core   +1 more source

Home - About - Disclaimer - Privacy